• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌和乳腺癌脑转移的时间及性别相关趋势。

Temporal and gender-related trends in brain metastases from lung and breast cancer.

作者信息

Yawn Barbara P, Wollan Peter C, Schroeder Clayton, Gazzuola Lilianna, Mehta Minesh

机构信息

Olmsted Medical Center, Rochester, USA.

出版信息

Minn Med. 2003 Dec;86(12):32-7.

PMID:14719614
Abstract

Increased duration of cancer survival may allow a longer window for detection of metastases, including brain metastases. Using the entire population of Olmsted County, Minnesota, we looked at trends in the rate of brain metastases in people diagnosed with primary lung or breast cancers between January 1, 1988, and December 31, 2001. Yearly rates of brain metastases detection following the primary tumors were calculated from a combination of medical record and SEER database information. Trends in rates and gender differences were assessed. There was no discernible increase in the rates of brain metastases secondary to lung or breast cancer during the period of observation. However, women were twice as likely as men to have brain metastases detected following a primary lung cancer. This difference was constant over the time period. This twofold difference in brain metastases detected in women versus men with lung cancer deserves further evaluation and confirmation.

摘要

癌症生存期的延长可能会为转移灶(包括脑转移灶)的检测提供更长的窗口期。我们利用明尼苏达州奥尔姆斯特德县的全体居民数据,研究了1988年1月1日至2001年12月31日期间被诊断为原发性肺癌或乳腺癌的患者发生脑转移的比率趋势。根据病历和监测、流行病学与最终结果(SEER)数据库信息的综合数据,计算出原发性肿瘤后每年的脑转移检测率。评估了比率趋势和性别差异。在观察期内,继发于肺癌或乳腺癌的脑转移率没有明显增加。然而,原发性肺癌后检测到脑转移的女性可能性是男性的两倍。这一差异在整个时间段内保持不变。女性与男性肺癌患者脑转移检测的这两倍差异值得进一步评估和确认。

相似文献

1
Temporal and gender-related trends in brain metastases from lung and breast cancer.肺癌和乳腺癌脑转移的时间及性别相关趋势。
Minn Med. 2003 Dec;86(12):32-7.
2
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.在底特律大都市癌症监测系统中确诊(1973年至2001年)的患者中脑转移瘤的发病比例。
J Clin Oncol. 2004 Jul 15;22(14):2865-72. doi: 10.1200/JCO.2004.12.149.
3
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.原发性乳腺癌患者脑转移的流行病学与经济负担:来自美国索赔数据分析的结果
Breast Cancer Res Treat. 2008 Mar;108(2):297-305. doi: 10.1007/s10549-007-9601-0. Epub 2007 Jun 19.
4
Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?局部晚期非小细胞肺癌脑转移的发生率和转归是否支持预防性颅脑照射或早期检测?
Lung Cancer. 2005 Jul;49(1):109-15. doi: 10.1016/j.lungcan.2004.12.004. Epub 2005 Feb 2.
5
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.
6
[The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].[原发性脑肿瘤或脑转移瘤患者的癫痫发作频率。来自维也纳凯撒·弗朗茨·约瑟夫医院路德维希·玻尔兹曼神经肿瘤学研究所和神经科的评估]
Wien Klin Wochenschr. 2002 Nov 30;114(21-22):911-6.
7
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.《1975 - 2002年全国癌症状况年度报告》,重点介绍基于人群的癌症治疗趋势。
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289.
8
Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.脑转移是接受根治性放化疗的Ⅲ期非小细胞肺癌患者远处转移的早期表现。
Am J Clin Oncol. 2008 Dec;31(6):561-6. doi: 10.1097/COC.0b013e318172d5f9.
9
Brain metastases in breast cancer: prognostic factors and management.乳腺癌脑转移:预后因素与治疗
Breast Cancer Res Treat. 2008 Oct;111(3):523-30. doi: 10.1007/s10549-007-9806-2. Epub 2007 Nov 8.
10
Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.男性与女性乳腺癌发病率趋势、肿瘤特征及生存率的比较。
Ann Epidemiol. 2005 Nov;15(10):773-80. doi: 10.1016/j.annepidem.2005.01.001.

引用本文的文献

1
Spatial Omics Profiling of Treatment-Naïve Lung Adenocarcinoma with Brain Metastasis as the Initial Presentation.以脑转移为首发表现的未经治疗的肺腺癌的空间组学分析
Cancers (Basel). 2025 Jul 31;17(15):2529. doi: 10.3390/cancers17152529.
2
FLAIR-based radiomics signature from brain-tumor interface for early prediction of response to EGFR-TKI therapy in NSCLC patients with brain metastasis.基于液体衰减反转恢复序列(FLAIR)的脑肿瘤界面放射组学特征,用于早期预测非小细胞肺癌脑转移患者对表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)治疗的反应
Front Cell Dev Biol. 2025 May 14;13:1525989. doi: 10.3389/fcell.2025.1525989. eCollection 2025.
3
Screening for Brain Metastases in Patients With NSCLC: A Qualitative Study on the Psychologic Impact of Being Diagnosed With Asymptomatic Brain Metastases.
非小细胞肺癌患者脑转移的筛查:一项关于被诊断为无症状脑转移的心理影响的定性研究。
JTO Clin Res Rep. 2022 Aug 27;3(10):100401. doi: 10.1016/j.jtocrr.2022.100401. eCollection 2022 Oct.
4
Utilization of combined PD-L1 expression and neutrophil-to-lymphocyte ratio prior to surgery as a prognostic factor in non-small cell lung cancer with brain metastasis.术前联合应用程序性死亡受体配体1(PD-L1)表达和中性粒细胞与淋巴细胞比值作为脑转移非小细胞肺癌的预后因素。
Transl Cancer Res. 2019 Dec;8(8):2864-2877. doi: 10.21037/tcr.2019.11.08.
5
The construction and validation of the model for predicting the incidence and prognosis of brain metastasis in lung cancer patients.预测肺癌患者脑转移发生率和预后模型的构建与验证
Transl Cancer Res. 2021 Jan;10(1):22-37. doi: 10.21037/tcr-20-2745.
6
Hippocampal avoidance in prophylactic cranial irradiation for small cell lung cancer: benefits and pitfalls.小细胞肺癌预防性颅脑照射中的海马回避:益处与陷阱
J Thorac Dis. 2021 May;13(5):3235-3245. doi: 10.21037/jtd-2019-rbmlc-01.
7
Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?在具有致癌基因依赖性的非小细胞肺癌中,酪氨酸激酶抑制剂治疗期间的中枢神经系统转移和寡进展:如何治疗及何时治疗?
Transl Lung Cancer Res. 2020 Dec;9(6):2599-2617. doi: 10.21037/tlcr-20-459.
8
Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy.脑转移瘤的分布:全脑放疗时可能避免低危转移区。
Cancer Imaging. 2020 Apr 22;20(1):29. doi: 10.1186/s40644-020-00309-y.
9
Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer.厄洛替尼对于 EGFR 基因突变的非小细胞肺癌脑转移与吉非替尼同样有效。
BMC Cancer. 2020 Jan 30;20(1):76. doi: 10.1186/s12885-020-6543-y.
10
The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).EGFR-TKI 治疗对脑转移后行伽玛刀放射外科治疗的肺腺癌患者临床结局的影响:基于扩展的 JLGK0901 数据集(JLGK0901-EGFR-TKI)的倾向性评分匹配分析。
J Neurooncol. 2019 Oct;145(1):151-157. doi: 10.1007/s11060-019-03282-0. Epub 2019 Sep 5.